✦ LIBER ✦
MP-08.12: One single dose of zoledronic acid (Zometa) annually can prevent bone mineral density (BMD) in patients with prostate cancer treated with LHRH: early results of a randomized trial
✍ Scribed by A. Lekas; M. Chrisofos; I. Fokitis; A. Balangas; A. Kollias; C. Deliveliotis
- Book ID
- 116948009
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 87 KB
- Volume
- 70
- Category
- Article
- ISSN
- 0090-4295
No coin nor oath required. For personal study only.